MedPath

Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency

Phase 2
Completed
Conditions
Acute Urticaria
Interventions
Drug: placebo
Drug: prednisone
Registration Number
NCT02565680
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Acute urticaria is common and affected 12% of population. 400 patients come in department emergency of Toulouse each year and there aren't many studies in literature which evaluate the glucocorticoids treatment. The standard treatment of urticaria is antihistamines H1, but glucocorticoids treatment administered orally for short course would permit to increase quickly acute urticaria uncomplicated. Clinical trial, prospective randomized double blinded of adults with acute urticaria less 24 hours duration and no take treatment urticaria before.

Detailed Description

Acute urticaria is common and affected 12% of population. 400 patients come in department emergency of Toulouse each year and there aren't many studies in literature which evaluate the glucocorticoids treatment. Acute urticaria is pruritic and incapacitating for daily life. The standard treatment of urticaria is antihistamines H1, but glucocorticoids treatment administered orally for short course would permit to increase quickly acute urticaria uncomplicated. Clinical trial, prospective randomized double blinded of adults with acute urticaria less 24 hours duration and no take treatment urticaria before. One group randomized received 40mg of cortancyl and 1 pill of citerizine and another group randomized received 1 pill citerizine and placebo like cortancyl. Pharmacy hospital takes care of randomization. Pruritus evaluated with icth score and rash evaluated with nine rule of Wallace, the patient is evaluated in T0, one hour after and contacted by telephone at J2, J5, J15, J 21 itch score, Wallace extension, observance, side effects are asked him.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • adults
  • urticaria rash no more 24 h duration and no take treatment for urticaria
Read More
Exclusion Criteria
  • patients were presented severe anaphylaxis or taken antihistamines or glucocorticoids within 5 days of arrival at ED,
  • severe infection
  • pregnancy
  • patients BPCO
  • diabetics
  • allergy corticosteroids
  • refusal to comply
  • participate an other study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplacebotablets of Xyzall 5mg/ day during 5 days + placebo 40mg/ day during 4 days
prednisoneprednisonetablets of Xyzall 5 mg/j during 5 days + prednisone 40 mg/ day during 4 days
Primary Outcome Measures
NameTimeMethod
To compare treatment with prednisone and antihistamines versus antihistamines placebo to out acute urticaria in 48 hours48 hours

To compare treatment with prednisone and antihistamines versus antihistamines placebo to out acute urticaria in 48 hours using the itch score

Secondary Outcome Measures
NameTimeMethod
Evolution of intensity pruritus, angioedema and rash with nine rule of Wallace21 days

Evolution of intensity pruritus at T0 and T1, J2, J5, J15, J21 and angioedema and rash at T1, J2, J5, J15 and J21 comparing at T0 with nine rule of Wallace

Recidive of urticaria21 days

The recidive of urticaria

The frequency of side-effects in either treatment group in 21 days21 days

The frequency of side-effects in either treatment group in 21 days

The observance treatment21 days

Observance treatment

The necessary time to decrease pruritus and rash21 days

The necessary time to decrease pruritus and rash

Trial Locations

Locations (1)

CHU Toulouse

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath